Liporetro-D-peptides - A novel class of highly selective thrombin inhibitors

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Poyarkov, Alexey A ^a   Poyarkova, Svetlana A ^a   Smirnova, Irina V ^b   Kukhar, Valery P ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY AND PETROCHEMISTRY   (Ukraine)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Anticoagulant; Inhibitor; Liporetro D peptide; Selectivity; Serine protease; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 10; DEXTRO ARGININE; DEXTRO PHENYLALANINE; LAURIC ACID; LIPOPEPTIDE; LIPORETRO D PEPTIDE; MYRISTIC ACID; PLASMIN; THROMBIN; THROMBIN INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; ENZYMATIC DEGRADATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANTITHROMBINS; BINDING SITES; ENZYME ACTIVATION; PEPTIDES; PROTEIN BINDING; THROMBIN;

EID: 84858341719     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.009     Document Type: Article

References (26)

1. A. Schwienhorst Direct thrombin inhibitors - a survey of recent developments Cell Mol Life Sci 63 2006 2773 2791
2. H.C. Castro, P.A. Abreu, R.B. Geraldo, R.C.A. Martins, R. dos Santos, and N.I.V. Loureiro Looking at the proteases from a simple perspective J Mol Recognit 24 2011 165 181
3. J.A. Huntington Molecular recognition mechanisms of thrombin J Thromb Haemost 3 2005 1861 1872
4. S.A. Poiarkova, V.K. Kibirev, and S.B. Serebrianyi Inhibition of the proteolytic activity of thrombin by methyl esters of arginine-containing oligopeptides Ukr Biokhim Zh 58 1986 3 8
5. M.A. Haga, M. Raba, S.A. Poyarkova, L.P. Shvachko, and V.K. Kibirev Purification of thrombin by affinity chromatography Chem Abstr 113 1990 878 SU1989
6. A. Poyarkov, X. Rocabayera, S. Poyarkova, and V. Kukhar Influence of aromatic and aliphatic moieties on thrombin inhibitors potency Open Biochem J 2 2008 143 149
7. J.W. Fenton II, M.J. Fasco, and A.B. Stackrow Human thrombins. Production, evaluation, and properties of alpha-thrombin J Biol Chem 252 1977 3587 3598
8. G.E. Perlmann, and L. Lorand Proteolytic enzymes 1970 Academic Press New York
9. W. Bode, D. Turk, and A. Karshikov The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships Protein Sci 1 1992 426 471
10. K. Hilpert, J. Ackermann, D.W. Banner, A. Gast, K. Gubernator, and P. Hadvary Design and synthesis of potent and highly selective thrombin inhibitors J Med Chem 37 1994 3889 3901
11. W.G. Eisert, N. Hauel, J. Stangier, W. Wienen, A. Clemens, and J. van Ryn Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin Arterioscler Thromb Vasc Biol 30 2010 1885 1889
12. D. Riester, F. Wirsching, G. Salinas, M. Keller, M. Gebinoga, and S. Kamphausen Thrombin inhibitors identified by computer-assisted multiparameter design Proc Natl Acad Sci U S A 102 2005 8597 8602
13. S. Bajusz, E. Szell, D. Bagdy, E. Barabas, G. Horvath, and M. Dioszegi Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H J Med Chem 33 1990 1729 1735
14. S.F. Brady, J.T. Sisko, K.J. Stauffer, C.D. Colton, H. Qiu, and S.D. Lewis Amide and [alpha]-keto carbonyl inhibitors of thrombin based on arginine and lysine: Synthesis, stability and biological characterization Bioorg Med Chem 3 1995 1063 1078
15. D. Gustafsson, J. Nystrom, S. Carlsson, U. Bredberg, U. Eriksson, and E. Gyzander The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects Thromb Res 101 2001 171 181
16. P. Préville, J.X. He, M. Tarazi, M.A. Siddiqui, W.L. Cody, and A.M. Doherty An efficient preparation of the potent and selective pseudopeptide thrombin inhibitor, inogatran Bioorg Med Chem Lett 7 1997 1563 1566
17. D. Noteberg, J. Branalt, I. Kvarnstrom, M. Linschoten, D. Musil, and J.E. Nystrom New proline mimetics: synthesis of thrombin inhibitors incorporating cyclopentane- and cyclopentenedicarboxylic acid templates in the P2 position. Binding conformation investigated by X-ray crystallography J Med Chem 43 2000 1705 1713
18. J. Das, and S. David Kimball Thrombin active site inhibitors Bioorg Med Chem 3 1995 999 1007
19. T.A. Lyle, Z. Chen, S.D. Appleby, R.M. Freidinger, S.J. Gardell, and S.D. Lewis Synthesis, evaluation, and crystallographic analysis of L-371,912: A potent and selective active-site thrombin inhibitor Bioorg Med Chem Lett 7 1997 67 72
20. W. Bode, I. Mayr, U. Baumann, R. Huber, S.R. Stone, and J. Hofsteenge The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment EMBO J 8 1989 3467 3475
21. M.T. Stubbs, and W. Bode A player of many parts: the spotlight falls on thrombin's structure Thromb Res 69 1993 1 58
22. R.C. Isaacs, M.G. Solinsky, K.J. Cutrona, C.L. Newton, A.M. Naylor-Olsen, and J.A. Krueger Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles Bioorg Med Chem Lett 16 2006 338 342
23. F. Kratz Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles J Control Release 132 2008 171 183
24. R.I. Senderoff, M.T. Sheu, and T.D. Sokoloski Fibrin based drug delivery systems J Parenter Sci Technol 45 1991 2 6
25. P. Home, and P. Kurtzhals Insulin detemir: from concept to clinical experience Expert Opin Pharmacother 7 2006 325 343
26. F. Kratz Drug conjugates with albumin and transferrin Expert Opin Ther Pat 12 2002 433 439